Nanocyl SA
46.7 FTENanocyl reported total assets of €13.2m at the end of the 2026 financial year (annual accounts filed with the NBB on 10 Jul 2026), with 46.7 full-time equivalents.
The score of Nanocyl shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2024 → 2026: Equity -13 % Total assets +31 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nanocyl's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 10 Jul 2026
- Year ended 31 Mar 2025filed on 19 Jun 2025
- Year ended 31 Mar 2024filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 12 May 2022
Nanocyl's financial analysis
- Solvency14.3%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nanocyl
Nanocyl's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.998.785
- VAT number
- BE0476998785
- Peppol
- Registered · 0208:0476998785 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 04 Mar 2002
- Registered office
- 5060 Sambreville
- Size
- Small · 46.7 FTE
- Latest accounts
- 2026 · filed on 10 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Nanocyl (SA) has been based in Sambreville since 2002, active in: research and experimental development on biotechnology. For 2026, it reports a net loss of 317,964 € and equity of €1.89m; its revenue is not published. With 46.7 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 14.3%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Nanocyl
Companies in the same business, of comparable size and area, outside its group.
- Biotalys Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.3m
- Confo Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €37.8m
- EXO Biologics Research and experimental development on natural sciences and engineering Liège · balance sheet €11.7m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Augustine Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €30.9m
Frequently asked questions about Nanocyl
What is the revenue of Nanocyl?
Nanocyl files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Nanocyl?
In Belgium, the VAT number is the company number prefixed with BE: BE0476998785 for Nanocyl, if the company is VAT-registered. Its company number (CBE) is 0476.998.785.
Where is the registered office of Nanocyl?
According to the CBE register, the registered office of Nanocyl is in 5060 Sambreville.
What is the equity of Nanocyl?
At the close of the 2026 financial year, the equity of Nanocyl amounts to 1,892,398 €, a solvency of 14.3% of total assets.
How many people work at Nanocyl?
46.7 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Nanocyl?
The register lists 4 active mandates at Nanocyl. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nanocyl
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →